| evaluate efficacy | 0.65 |
| assess tolerability | 0.49 |
| assess pharmacokinetic | 0.42 |
| enrol patient | 0.41 |
| involve patient | 0.38 |
| recruit participant | 0.38 |
| use telemonitoring | 0.32 |
| evaluate cndo-109-activ… | 0.25 |
| match patient | 0.25 |
| underway | 0.66 |
| ongoing | 0.57 |
| successful | 0.50 |
| positive | 0.29 |
| useful | 0.25 |
| conducted | 0.77 |
| completed | 0.63 |
| randomised | 0.45 |
| designed to speed up th… | 0.25 |
| warranted | 0.25 |
| conducted in india | 0.25 |
| terminated | 0.16 |